DeepSeek Dials Up the Pressure on OpenAI and Anthropic With Open-Source Inference Tool
THE SO WHAT
An open-source inference platform like DeepInfer that explicitly targets U.S. enterprises is another step in Chinese open models competing on cost and flexibility, not just benchmarks. If you’re standardizing your AI stack, you now have to weigh geopolitical and compliance risk alongside TCO when considering Chinese-origin tooling.
READ THE SOURCE
MORE FROM THE WIRE
Applied AIPartnering with Blacksmith
If agents can write production-scale code, the new bottleneck is proving that code is safe, performant, and compliant at the same speed. Expect “agent-era CI/CD” vendors like Blacksmith to become a required layer in any serious agent deployment, not a nice-to-have devtool.
Applied AIRussia drafted plans for AI that could block 95% of VPNs — but the idea has quietly vanished from its national roadmap
States are experimenting with ML as a censorship accelerator, but even Russia is blinking at the collateral damage risk. If your product depends on open internet access in restrictive regimes, assume AI-augmented blocking will keep advancing even when it drops off official roadmaps.
Applied AIOpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind
AI agents moving into end-to-end drug program management means the battle in pharma is shifting from point tools to workflow ownership. If you’re a biotech operator, assume the default stack will bundle model, agent, and domain-specific orchestration — and plan your data and process control points accordingly.
Applied AISeeing Some AI-To-AI Crypto Commerce: Jardine
138 million+ autonomous agent transactions on Base is early evidence that AI-to-AI commerce is not just a demo. If you touch payments or marketplaces, you need a view on how you’ll authenticate, price, and risk-score non-human counterparties transacting at machine speed.